loxoprofen has been researched along with Fibrosis, Inflammatory Perianeurysmal in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiya, E | 1 |
| Ishizaka, N | 1 |
| Watanabe, A | 1 |
| Endo, Y | 1 |
| Itou, R | 1 |
| Yoshida, S | 1 |
| Nangaku, M | 1 |
| Nagai, R | 1 |
1 other study available for loxoprofen and Fibrosis, Inflammatory Perianeurysmal
| Article | Year |
|---|---|
Retroperitoneal fibrosis with periaortic and pericardial involvement.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Hormonal; Aorta; Humans; Male; | 2005 |